10-Q: Knowles Corporation Reports Q2 2024 Results, Impacted by Goodwill Impairment

Sentiment:

Quarterly Report


Knowles Corporation's second quarter results were significantly impacted by a $249.4 million goodwill impairment charge in its Consumer MEMS Microphones segment, leading to a net loss.

Worse than expectedThe company reported a significant net loss of $259.3 million, compared to a net income of $13.6 million in the same period last year.The company recorded a substantial goodwill impairment charge of $249.4 million in the Consumer MEMS Microphones segment.Gross profit margin decreased to 37.9% from 42.6% due to pricing pressures and acquisition impacts.

Summary

  • Knowles Corporation reported a net loss of $259.3 million for the second quarter of 2024, compared to a net income of $13.6 million in the same period last year.
  • The company's revenue increased to $204.7 million, up from $173.0 million in Q2 2023, driven by the acquisition of Cornell Dubilier and higher demand in certain markets.
  • A significant goodwill impairment charge of $249.4 million was recorded in the Consumer MEMS Microphones segment due to a strategic review of the business.
  • Gross profit increased to $77.6 million, but gross profit margin decreased to 37.9% due to pricing pressures and acquisition impacts.
  • Operating expenses increased significantly to $313.2 million, primarily due to the goodwill impairment.
  • The company's interest expense increased to $4.6 million due to the seller note from the Cornell Dubilier acquisition and higher revolving credit facility balance.
  • Basic and diluted loss per share were both $2.90 for the quarter.
  • For the six months ended June 30, 2024, the net loss was $256.8 million, compared to a net income of $8.4 million in the same period last year.
  • The company repurchased 1,432,989 shares of common stock for $25.0 million during the six months ended June 30, 2024.

Sentiment

Score: 3

Explanation: The document indicates a significant net loss and a substantial goodwill impairment, which are major negative factors. While there is revenue growth, the overall financial performance is concerning, leading to a low sentiment score.

Positives

  • Revenue increased by 18.3% year-over-year to $204.7 million, indicating growth in sales.
  • The Precision Devices segment saw a revenue increase of $26.3 million due to the Cornell Dubilier acquisition and higher demand from the medtech market.
  • Consumer MEMS Microphones revenues increased by $6.5 million due to higher demand in mobile, ear, and IoT markets.
  • The company's MedTech & Specialty Audio segment saw higher shipping volumes of hearing health products driven by stronger end market demand.
  • Non-GAAP gross profit for the second quarter of 2024 was $79.7 million, compared with $72.7 million for the second quarter of 2023, an increase of $7.0 million or 9.6%.

Negatives

  • The company reported a significant net loss of $259.3 million for Q2 2024.
  • A goodwill impairment charge of $249.4 million was recorded in the Consumer MEMS Microphones segment.
  • Gross profit margin decreased to 37.9% from 42.6% due to pricing pressures and acquisition impacts.
  • Operating expenses increased significantly to $313.2 million, primarily due to the goodwill impairment.
  • Interest expense increased to $4.6 million due to the seller note from the Cornell Dubilier acquisition and a higher revolving credit facility balance.
  • The MedTech & Specialty Audio segment experienced a decrease in revenue of $1.1 million due to lower shipping volumes into the specialty audio market.

Risks

  • The company faces risks related to the strategic review of the Consumer MEMS Microphones business, which could result in a sale or restructuring.
  • There is a risk of further impairment charges due to future events or changes in assumptions used to calculate fair value.
  • The company is exposed to fluctuations in operating results and cash flows.
  • There are risks associated with increasing inventories in advance of anticipated orders.
  • The company is subject to global economic instability, including inflation and geopolitical uncertainties.
  • The company faces risks related to competition and new entrants in the market.
  • There are risks associated with reliance on third parties for manufacturing and assembly.
  • The company is exposed to financial risks, including currency fluctuations and credit risks.

Future Outlook

The company expects to reduce its cash balance in the second half of the year, primarily driven by the payment of the Seller Note related to the CD acquisition and debt reduction, partially offset by cash generated from operations. The company expects capital expenditures to be in the range of 2.0% to 3.0% of revenues.

Management Comments

  • The company is reviewing strategic alternatives for the CMM business, which could include a sale or restructuring.
  • Management believes that future cash flow from operations and access to capital markets will provide adequate resources to fund working capital needs, capital expenditures, strategic investments, and share repurchases.

Industry Context

The company's performance is influenced by demand in the medtech, defense, electric vehicle, industrial, communications, and consumer electronics markets. The strategic review of the CMM business reflects challenges in the MEMS microphone market. The acquisition of Cornell Dubilier is part of the company's strategy to diversify its end markets and customers.

Comparison to Industry Standards

  • The significant goodwill impairment charge of $249.4 million is unusual and indicates a potential overvaluation of the CMM business, which is a negative signal compared to industry standards.
  • The decrease in gross profit margin to 37.9% from 42.6% suggests pricing pressures and integration challenges, which is below the industry average for similar technology companies.
  • The increase in operating expenses to $313.2 million, primarily due to the goodwill impairment, is a significant deviation from industry norms and indicates a need for cost management.
  • The increase in interest expense to $4.6 million due to the seller note from the Cornell Dubilier acquisition and a higher revolving credit facility balance is a common occurrence after acquisitions, but the magnitude is higher than average.
  • The company's revenue growth of 18.3% is positive, but the net loss of $259.3 million indicates that the company is not effectively converting revenue into profit, which is a concern compared to industry benchmarks.
  • The company's share repurchase program is a common practice, but the timing and amount of repurchases should be carefully considered in light of the current financial performance.

Stakeholder Impact

  • Shareholders are negatively impacted by the significant net loss and goodwill impairment.
  • Employees may be affected by potential restructuring activities in the CMM segment.
  • Customers may experience changes in product offerings or pricing due to the strategic review of the CMM business.
  • Creditors are exposed to increased risk due to the company's financial performance.

Next Steps

  • The company will continue to review strategic alternatives for the CMM business.
  • The company will focus on integrating the Cornell Dubilier acquisition.
  • The company will manage its cash balance, including the payment of the Seller Note.
  • The company will continue to monitor market conditions and adjust its operations as needed.

Key Dates

DateDescription
2020-02-24The company announced a share repurchase program of up to $100 million.
2022-04-28The company increased the share repurchase authorization by up to $150 million.
2023-02-08The company entered into an Amended and Restated Credit Agreement.
2023-09-18The company announced a review of strategic alternatives for the CMM business.
2023-09-25The company amended its A&R Credit Agreement to permit seller financing for the Cornell Dubilier acquisition.
2023-11-01The company acquired Cornell Dubilier.
2024-05-15John Anderson adopted a Rule 10b5-1 trading plan.
2024-05-17Daniel Giesecke adopted a Rule 10b5-1 trading plan.
2024-06-17The company obtained consent from lenders to consummate a specified disposition.
2024-06-30End of the reporting period for the quarterly results.
2024-07-29Number of shares outstanding of the registrants common stock was 88,427,283.
2024-07-31Date of the report.

Keywords

Goodwill Impairment, MEMS Microphones, Capacitors, Audio Solutions, MedTech, Consumer Electronics, Financial Results, Acquisition, Restructuring, Share Repurchase

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.